* Repligen Corp RGEN.OQ RGEN.O is expected to show a
rise in
quarterly revenue when it reports results on November 12 for
the period ending September 30 2024
* The Waltham Massachusetts-based company is expected to
report a
8.5% increase in revenue to $153.23 million from $141.19 million
a year ago, according to the mean estimate from 15 analysts,
based on LSEG data. (DECY Quarters may not add to annual due to
restatement of actual)
* LSEG's mean analyst estimate for Repligen Corp is for
earnings
of 33 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Repligen
Corp is
$190.00, above its last closing price of $143.88.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 0.33 0.33 0.33 Met 1.2
Mar. 31 2024 0.30 0.30 0.28 Missed -7.2
Dec. 31 2023 0.33 0.33 0.33 Met 1.4
Jan. 1 0001 0.17 0.17 0.23 Beat 38.7
Jun. 0.48 0.48 0.53 Beat 11.5
30 2023
Jan. 1 0001 0.59 0.59 0.64 Beat 9
Dec. 31 2022 0.57 0.58 0.68 Beat 17.8
Sep. 30 2022 0.68 0.68 0.77 Beat 13.2
This summary was machine generated November 8 at 16:56 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)